FCI Ophthalmics
Pembroke, MA - FCI Ophthalmics, Inc. is pleased to introduce the OphtaCath lacrimal duct balloon catheter which achieves true dilation of the lacrimal duct and rapidly and effectively treats the symptoms of epiphora. OphtaCath is a less invasive alternative to incisional procedures such as DCR and eliminates the placement of tubes, resulting in less trauma.
OphtaCath comes packaged sterile in 2MM or 3MM kits with one or two balloon catheters and a highly precise and easy to use disposable inflation device.
OphtaCath’s exclusive tapered tip and very low profile allows for easy insertion and removal of the balloon catheter. The OphtaCath exclusive balloon design features excellent shape memory before and after inflation and is exceptionally resistant to burst pressure. The semi-flexible balloon ensures a progressive inflation and remarkable precision.
Now approved for sale in the United States, OphtaCath is available only from FCI Ophthalmics, Inc., the leader in lacrimal surgery products. FCI Ophthalmics can be reached by calling 1-800-932-4202, via email at [email protected] or by fax at 1-781-826-9062.